Clinical assessment and outcome research in spondyloarthritis
Tóm tắt
Từ khóa
Tài liệu tham khảo
van der Heijde D, Calin A, Dougados M, et al.: Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 1999, 26:951–954.
Jenkinson TR, Mallorie PA, Whitelock HC, et al.: Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994, 21:1694–1698.
Jones SD, Porter J, Garrett SL, et al.: A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol 1995, 22:1609.
van der Heijde D, Landewe R, Feldtkeller E: Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions. Ann Rheum Dis 2008, 67:489–493.
Maksymowych WP, Mallon C, Richardson R, et al.: Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index. Arthritis Rheum 2006, 55:575–582.
Gladman DD, Inman RD, Cook RJ, et al.: International spondyloarthritis interobserver reliability exercise—the INSPIRE study: I. Assessment of spinal measures. J Rheumatol 2007, 34:1733–1739.
Haywood KL, Garratt AM, Jordan K, et al.: Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 2004, 43:750–757.
Fernandez-Sueiro JL, Willisch A, Pertega-Diaz SP, et al.: Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum 2009, 61:386–392.
McGonagle D, Gibbon W, Emery P: Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137–1140.
Balint PV, Kane D, Wilson H, et al.: Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002, 61:905–910.
Mander M, Simpson JM, McLellan A, et al.: Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987, 46:197–202.
Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al.: Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003, 62:127–132.
Braun J, Brandt J, Listing J, et al.: Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002, 359:1187–1193.
Gladman DD, Cook RJ, Schentag C, et al.: The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 2004, 31:1126–1131.
Healy PJ, Helliwell PS: Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008, 59:686–691.
Gladman DD, Inman RD, Cook RJ, et al.: International spondyloarthritis interobserver reliability exercise-the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007, 34:1740–1745.
van der Heijde D, Lie E, Kvien TK, et al.: The ASDAS is a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2008 Dec 5 (Epub ahead of print).
Lukas C, Landewe R, Sieper J, et al.: Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68:18–24.
Pham T, Landewe R, van der Linden S, et al.: An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis 2006, 65:1620–1625.
van der Heijde DM, van’t Hof M, van Riel PL, van de Putte LB: Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993, 20:579–581.
Leeb BF, Andel I, Sautner J, et al.: The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients. Arthritis Rheum 2007, 57:256–260.
Fransen J, Antoni C, Mease PJ, et al.: Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006, 65:1373–1378.
Wanders AJ, Landewe RB, Spoorenberg A, et al.: What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004, 50:2622–2632.
Zochling J, van der Heijde D, Burgos-Vargas R, et al.: ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006, 65:442–452.
Creemers MC, Franssen MJ, van’t Hof MA, et al.: Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005, 64:127–129.
van der Heijde D, Landewe R: Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT. J Rheumatol 2005, 32:2048–2049.
van der Heijde D, Sharp J, Wassenberg S, Gladman DD: Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis 2005, 64:ii61–ii64.
van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361–368.
MacKay K, Brophy S, Mack C, et al.: The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 2000, 27:2866–2872.
MacKay K, Mack C, Brophy S, Calin A: The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 1998, 41:2263–2270.
Kane D: The role of ultrasound in the diagnosis and management of psoriatic arthritis. Curr Rheumatol Rep 2005, 7:319–324.
Kane D, Greaney T, Bresnihan B, et al.: Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999, 26:1746–1751.
Fiocco U, Ferro F, Vezzu M, et al.: Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 2005, 64:899–905.
D’Agostino MA, Breban M, Said-Nahal R, Dougados M: Refractory inflammatory heel pain in spondylarthropathy: a significant response to infliximab documented by ultrasound. Arthritis Rheum 2002, 46:840–841.
Delle Sedie A, Riente L, Bombardieri S: Limits and perspectives of ultrasound in the diagnosis and management of rheumatic diseases. Mod Rheumatol 2008, 18:125–131.
De Filippis LG, Caliri A, Lo Gullo R, et al.: Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int J Tissue React 2005, 27:159–162.
Unlu E, Pamuk ON, Cakir N: Color and duplex Doppler sonography to detect sacroiliitis and spinal inflammation in ankylosing spondylitis. Can this method reveal response to anti-tumor necrosis factor therapy? J Rheumatol 2007, 34:110–116.
Alcalde M, Acebes JC, Cruz M, et al.: A sonographic enthesitic index of lower limbs is a valuable tool in the assessment of ankylosing spondylitis. Ann Rheum Dis 2007, 66:1015–1019.
Baraliakos X, Landewe R, Hermann KG, et al.: Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 2005, 64:730–734.
Braun J, Baraliakos X, Golder W, et al.: Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 2004, 63:1046–1055.
Oostveen J, Prevo R, den Boer J, van de Laar M: Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 1999, 26:1953–1958.
Battafarano DF, West SG, Rak KM, et al.: Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis. Semin Arthritis Rheum 1993, 23:161–176.
Wiell C, Szkudlarek M, Hasselquist M, et al.: Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 2007, 9:R119.
Braun J, Landewe R, Hermann KG, et al.: Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006, 54:1646–1652.
Marzo-Ortega H, McGonagle D, Rhodes LA, et al.: Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis 2007, 66:778–781.
Marzo-Ortega H, McGonagle D, O’Connor P, Emery P: Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum 2001, 44:2112–2117.
Lambert RG, Salonen D, Rahman P, et al.: Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2007, 56:4005–4014.
Baraliakos X, Davis J, Tsuji W, Braun J: Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 2005, 52:1216–1223.
Haibel H, Rudwaleit M, Listing J, et al.: Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 2008, 58:1981–1991.
Rudwaleit M, Schwarzlose S, Hilgert ES, et al.: MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008, 67:1276–1281.
Braun J, Baraliakos X, Golder W, et al.: Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003, 48:1126–1136.
Rudwaleit M, Baraliakos X, Listing J, et al.: Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis 2005, 64:1305–1310.
Maksymowych WP, Inman RD, Salonen D, et al.: Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum 2005, 53:502–509.
Maksymowych WP, Inman RD, Salonen D, et al.: Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005, 53:703–709.
van der Heijde D, Landewe R, Hermann KG, et al.: Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis? J Rheumatol 2007, 34:871–873.
McQueen F, Lassere M, Bird P, et al.: Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis. J Rheumatol 2007, 34:859–861.
Rudwaleit M, Landewe R, van der Heijde D, et al.: The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009, 68:770–776.
Rudwaleit M, van der Heijde D, Landewe R, et al.: The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68:777–783.
Rudwaleit M, Khan MA, Sieper J: The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 2005, 52:1000–1008.
van der Heijde D, Landewe R, Einstein S, et al.: Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008, 58:1324–1331.
van der Heijde D, Landewe R, Baraliakos X, et al.: Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008, 58:3063–70.